Moderna says its coronavirus vaccine won’t be ready until 2021
Editor's Picks

Moderna says its coronavirus vaccine won’t be ready until 2021

Moderna CEO Stéphane Bancel said Wednesday that his company’s coronavirus vaccine won’t be available for widespread distribution until at least spring 2021, according to Financial Times.

Why it matters: Bancel told FT that the drugmaker will not seek emergency authorization for Food and Drug Administration approval for its vaccine to use in frontline medical workers and at-risk individuals until Nov. 25 at the earliest.

  • He added the company would not seek FDA approval for use in the general population until late January.
  • If the vaccine is proven safe and effective, approval is unlikely to come until at least late March or early April.

What they’re saying: “I think a late [first quarter], early [second quarter] approval is a reasonable timeline, based on what we know from our vaccine,” Bancel said, according to the FT.

The big picture: Moderna’s vaccine is one of four that are currently in late-stage testing in people in the U.S.

  • The Trump administration in August announced it purchased 100 million doses of Moderna’s experimental coronavirus vaccine for $1.5 billion, or $15 per dose.
  • The president has repeatedly claimed that a vaccine will be available for widespread distribution before the end of the year, though CDC Director Robert Redfield testified to Congress that it’s more likely a vaccine won’t be available until the second or third quarter of next 2021.

Read More : Source

Related posts

Hydroxychloroquine didn’t prevent Covid-19 among health care workers in new study

Donald Trump Claims Joe Biden Wants to Cancel Remaining Debates—He Doesn’t

The new Chromecast with Google TV will get an Ethernet adapter, but it will cost $20

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More